|
|
|
Volumn 22, Issue 3, 2012, Pages 407-413
|
|
[Evidence in the treatment of osteoporosis using weekly teriparatide injections].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
BONE DENSITY CONSERVATION AGENT;
COLLAGEN TYPE 1;
COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE;
COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE;
OSTEOCALCIN;
PARATHYROID HORMONE[1-34];
PEPTIDE;
BLOOD;
BONE DENSITY;
DRUG EFFECT;
EVIDENCE BASED MEDICINE;
FRAGILITY FRACTURE;
HUMAN;
OSTEOLYSIS;
OSTEOPOROSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
RISK;
SUBCUTANEOUS DRUG ADMINISTRATION;
URINE;
BIOLOGICAL MARKERS;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
BONE RESORPTION;
COLLAGEN TYPE I;
EVIDENCE-BASED MEDICINE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
OSTEOCALCIN;
OSTEOPOROSIS;
OSTEOPOROTIC FRACTURES;
PEPTIDES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK;
TERIPARATIDE;
|
|
EID: 84866177300
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
